Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
Oncology
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| Zidesamtinib | Nuvalent, Inc. (NUVL) |
Frequently asked questions
How many drugs are in development for Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer?
BioSniper tracks 1 drug in development for Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer across 1 company.
How many clinical trials target Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer?
There are 1 clinical trial targeting Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer tracked by BioSniper.
Deep-dive into Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis